How to Achieve International Action on Falsified and Substandard Medicines

BMJ, 2012, DOI: 10.1136/bmj.e7381

6 Pages Posted: 20 Nov 2012

See all articles by Amir Attaran

Amir Attaran

University of Ottawa - Department of Epidemiology and Community Medicine; University of Ottawa - Common Law Section

Donna Barry

Partners in Health

Shamnad Basheer

Nirma University - Institute of Law

Roger Bate

American Enterprise Institute (AEI)

David Benton

International Council of Nurses

James Chauvin

World Federation of Public Health Associations

Laurie Garrett

Council on Foreign Relations (CFR)

Ilona Kickbusch

Graduate Institute of International and Development Studies

Jillian C. Kohler

Leslie Dan Faculty of Pharmacy, University of Toronto

Kamal Midha

International Pharmaceutical Federation

Paul Newton

University of Oxford

Sania Nishtar

Heartfile

Paul Orhii

National Agency for Food and Drug Administration and Control

Martin McKee

London School of Hygiene and Tropical Medicine

Date Written: November 1, 2012

Abstract

Substandard and falsified medicines kill patients, yet progress on the twin challenges of safeguarding the quality of genuine medicine and criminalising falsified ones has been held back by controversy over intellectual property rights and confusion over terms. Amir Attaran and colleagues propose a global treaty to overcome the problems.

Keywords: substandard medicines, falsified medicines, global treaty

Suggested Citation

Attaran, Amir and Barry, Donna and Basheer, Shamnad and Bate, Roger and Benton, David and Chauvin, James and Garrett, Laurie and Kickbusch, Ilona and Kohler, Jillian C. and Midha, Kamal and Newton, Paul and Nishtar, Sania and Orhii, Paul and McKee, Martin, How to Achieve International Action on Falsified and Substandard Medicines (November 1, 2012). BMJ, 2012, DOI: 10.1136/bmj.e7381. Available at SSRN: https://ssrn.com/abstract=2178601

Amir Attaran (Contact Author)

University of Ottawa - Department of Epidemiology and Community Medicine ( email )

451 Smyth Road
Ottawa, Ontario K1H 8M5
Canada

University of Ottawa - Common Law Section ( email )

57 Louis Pasteur Street
Ottawa, K1N 6N5
Canada
613-562-5800 ext: 2015 (Phone)
613-562-5659 (Fax)

Donna Barry

Partners in Health ( email )

641 Huntington Ave, 1st Floor
Boston, MA 02115
United States

Shamnad Basheer

Nirma University - Institute of Law ( email )

Sarkhej-Gandhinagar Highway
Gota
Ahmedabad, Gujarat 382 481
India

Roger Bate

American Enterprise Institute (AEI) ( email )

1150 17th Street, N.W.
Washington, DC 20036
United States

David Benton

International Council of Nurses ( email )

Geneva
Switzerland

James Chauvin

World Federation of Public Health Associations ( email )

Geneva
Switzerland

Laurie Garrett

Council on Foreign Relations (CFR) ( email )

The Harold Pratt House
58 East 68th Street
New York, NY 10021
United States

Ilona Kickbusch

Graduate Institute of International and Development Studies ( email )

Rue de Lausanne 132
P.O. Box 136
Geneva, 1211
Switzerland

Jillian C. Kohler

Leslie Dan Faculty of Pharmacy, University of Toronto ( email )

144 College St.
Toronto, Ontario M5S 3M2
Canada

Kamal Midha

International Pharmaceutical Federation ( email )

The Hague
Netherlands

Paul Newton

University of Oxford ( email )

Mansfield Road
Oxford, Oxfordshire OX1 4AU
United Kingdom

Sania Nishtar

Heartfile ( email )

Islamabad
Pakistan

Paul Orhii

National Agency for Food and Drug Administration and Control ( email )

Abuja
Nigeria

Martin McKee

London School of Hygiene and Tropical Medicine ( email )

Keppel Street
Health Services Research Unit Professor of European Public Health
London WC1E 7HT
United Kingdom
+44 20 7-927 2229 (Phone)
+44 20 7-580 8183 (Fax)

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
145
Abstract Views
1,135
rank
215,283
PlumX Metrics